§ Miss McIntoshTo ask the Secretary of State for Health what the prescription rate of herceptin is in the(a) North of England, (b) south-east of England, (c) United Kingdom and (d) rest of the European Union; and if he will make a statement. [145935]
§ Ms StuartThe drug received its marketing authorisation on 28 August 2000, and information about its use is not yet available. We have asked the National Institute for Clinical Excellence to conduct an appraisal of Herceptin (trastuzumab) and vinorelbine for breast cancer. We expect NICE to issue guidance this summer.